Single-use Testosterone in Healthy Participants (PK Study)

The purpose of this work is to investigate the dose-response curve for intranasal testosterone in healthy young men and women. A large body of evidence has investigated links between baseline levels of testosterone and individual differences in human dominance behaviour, including behaviours that are intended to obtain or maintain a high social rank or status (Boksem et al., 2013). With a single intranasal administration of 0.3 mg testosterone in women, and 11 mg testosterone in men, it is predicted that these low doses of testosterone will lead to a rapid, and short-term rise in serum testosterone concentrations within the high-normal physiological range.

Register Today!

Trial Information

Start DateNovember 2020
End DateJanuary 2021
Trial Duration4 weeks
Number of Visits2 visits
Lead CRCAndrea Carruthers
StatusComplete

For additional information
on this trial contact:

Phone705-566-0005